- Home
- STRO vs VNRX Comparison
STRO vs VNRX Comparison
Compare STRO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- VNRX
- Stock Information
- Founded
- STRO 2003
- VNRX N/A
- Country
- STRO United States
- VNRX United States
- Employees
- STRO N/A
- VNRX N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- STRO Health Care
- VNRX Health Care
- Exchange
- STRO Nasdaq
- VNRX Nasdaq
- Market Cap
- STRO 69.1M
- VNRX 64.8M
- IPO Year
- STRO 2018
- VNRX N/A
- Fundamental
- Price
- STRO $0.97
- VNRX $0.64
- Analyst Decision
- STRO Hold
- VNRX Strong Buy
- Analyst Count
- STRO 7
- VNRX 4
- Target Price
- STRO $1.97
- VNRX $3.50
- AVG Volume (30 Days)
- STRO 553.4K
- VNRX 226.2K
- Earning Date
- STRO 08-07-2025
- VNRX 08-14-2025
- Dividend Yield
- STRO N/A
- VNRX N/A
- EPS Growth
- STRO N/A
- VNRX N/A
- EPS
- STRO N/A
- VNRX N/A
- Revenue
- STRO $104,473,000.00
- VNRX $1,319,252.00
- Revenue This Year
- STRO $65.42
- VNRX $274.46
- Revenue Next Year
- STRO N/A
- VNRX $212.60
- P/E Ratio
- STRO N/A
- VNRX N/A
- Revenue Growth
- STRO N/A
- VNRX 35.10
- 52 Week Low
- STRO $0.52
- VNRX $0.40
- 52 Week High
- STRO $4.80
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- STRO 58.41
- VNRX 46.34
- Support Level
- STRO $0.90
- VNRX $0.57
- Resistance Level
- STRO $1.18
- VNRX $0.73
- Average True Range (ATR)
- STRO 0.09
- VNRX 0.04
- MACD
- STRO 0.01
- VNRX -0.00
- Stochastic Oscillator
- STRO 43.43
- VNRX 41.88
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.